---
title: "RONG FENG HOLDING: Delay in the disclosure of the 2024 annual report and the 2025 first quarter report"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236990116.md"
description: "On the evening of April 22, RONG FENG HOLDING announced that the company was originally scheduled to disclose the \"2024 Annual Report\" and \"2025 First Quarter Report\" on April 26, 2025. According to the current progress of the periodic report preparation work, in order to ensure the accuracy and completeness of information disclosure, the company has applied to the Shenzhen Stock Exchange to adjust the disclosure date of the \"2024 Annual Report\" and \"2025 First Quarter Report\" to April 29, 2025"
datetime: "2025-04-22T13:35:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236990116.md)
  - [en](https://longbridge.com/en/news/236990116.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236990116.md)
---

# RONG FENG HOLDING: Delay in the disclosure of the 2024 annual report and the 2025 first quarter report

On the evening of April 22, RONG FENG HOLDING announced that the company was originally scheduled to disclose the "2024 Annual Report" and the "2025 First Quarter Report" on April 26, 2025. According to the current progress of the periodic report preparation work, in order to ensure the accuracy and completeness of the information disclosure, the company has applied to the Shenzhen Stock Exchange to adjust the disclosure time of the "2024 Annual Report" and the "2025 First Quarter Report" to April 29, 2025

### Related Stocks

- [000668.CN](https://longbridge.com/en/quote/000668.CN.md)

## Related News & Research

- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [Moving at the speed of pharma digitalisation: driving ROI from AI and digital tools](https://longbridge.com/en/news/296126091.md)
- [11:33 ETDuPage Regional Office of Education Expands Student Health and Wellness Supports Ahead of New School Year](https://longbridge.com/en/news/296126704.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)
- [CataCap buys majority stake in Danish data protection provider B4Restore](https://longbridge.com/en/news/296194758.md)